Newton, MA, United States of America

Aditi R Deshpande

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Allena Pharmaceuticals, Inc.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aditi R Deshpande. Retrieved from https://idiyas.com/inventor/aditi-r-deshpande

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Aditi R Deshpande: Innovator in Recombinant Uricase Enzymes

Introduction

Aditi R Deshpande is a notable inventor based in Newton, MA (US). She has made significant contributions to the field of biochemistry, particularly in the development of recombinant enzymes. Her work focuses on addressing health issues related to elevated uric acid levels.

Latest Patents

Aditi holds a patent for a recombinant uricase enzyme. This invention discloses recombinant mutant uricase enzymes with improved pancreatin stability and/or activity. These enzymes can be utilized in compositions aimed at treating diseases or disorders associated with elevated uric acid levels, such as hyperuricemia, hyperuricosuria, and gout. She has 1 patent to her name.

Career Highlights

Aditi is currently employed at Allena Pharmaceuticals, Inc., where she continues to advance her research and development efforts. Her work is pivotal in creating therapeutic solutions for patients suffering from conditions related to uric acid.

Collaborations

Aditi collaborates with talented professionals in her field, including Danica Grujic and Sridhar Govindarajan. These partnerships enhance the innovative potential of her projects and contribute to the success of her research endeavors.

Conclusion

Aditi R Deshpande is a remarkable inventor whose work on recombinant uricase enzymes has the potential to significantly impact the treatment of uric acid-related disorders. Her contributions to the field exemplify the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…